Market Cap | ₹11,937Cr |
ROE | 13.50% |
P/E Ratio(TTM) | 24.90 |
EPS(TTM) | 19.76 |
P/B Ratio | 3.21 |
Dividend Yield | 0.30% |
Industry P/E | 34.34 |
Book Value | 153.13 |
Debt to Equity | 0.39 |
Face Value | 1 |
Parent Organisation | Granules India Limited |
Managing Director | Dr. Kandiraju Rao |
NSE Symbol | GRANULES |
FUND NAME | AUM(%) |
---|---|
Axis Value Fund Direct Growth | 0.96% |
Tata Large Cap Direct Plan Growth | 0.96% |
Tata Mid Cap Direct Plan Growth | 0.95% |
Axis Multicap Fund Direct Growth | 0.94% |
COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
---|---|---|---|---|
Cohance Lifesciences | NA (0.00%) | 100.61 | ||
JB Chemicals & Pharmaceuticals | NA (0.00%) | 39.39 | ||
Emcure Pharmaceuticals | NA (0.00%) | 35.44 | ||
Wockhardt | NA (0.00%) | -188.59 |